Dr Louisa James, British Society for Immunology spokesperson, says considering the increased prevalence of food allergies over recent decades, new guidelines on the timing of introduction of allergenic food to the infant diet are warranted.
Dr Sheena Cruickshank, British Society for Immunology spokesperson, says without knowing more about how this work was carried out and how the studies were selected, it is hard to judge the robustness of this finding.
Dr Peter Barlow says study represents a promising step forward in the rapid development of a safe and robust vaccine against Zika virus infection in humans.
Professor Peter Openshaw, President of the British Society for Immunology, says immunology shares with other branches of science an in-built internationalism that must continue to thrive, whatever the political climate.
The BSI has released a statement in response to the UK Government announcement that two new vaccine programmes will be launched this September to protect babies and young people against the meningococcal bacterium.
The BSI has issued a statement in response to a paper reporting the trial results of two types of vaccine against the Zika virus in mice.
A new report out today highlights the benefits that working with international partners brings to immunology in the UK.
The BSI has issued a statement in response to a paper published today in the Proceedings of the National Academy of Sciences which reports that injecting mice with a heat-killed version of the bacteria Mycobacterium vaccae can reduce stress and inflammation in the animals, preventing them from developing post traumatic stress-like conditions.
Professor Daniel Altmann, British Society for Immunology spokesperson, says the current Zika virus outbreak has been especially alarming due to the association with a sharp spike in foetal microcephaly.
British allergy sufferers are to turn citizen scientists in a bid to decode the poorly understood world of seasonal allergies thanks to a free new app.
For the first time, scientists have identified how differences in individuals’ immune responses might be linked to the effectiveness of the seasonal influenza vaccination programme. The findings are published in the journal, Immunology.
Dr Peter Barlow, British Society for Immunology spokesperson, said the study provides evidence to suggest a causal link between Zika virus infection and Guillain-Barre syndrome in French Polynesia. However, there is still a significant amount of work to be undertaken before the same conclusions can be extended to the Zika outbreak in South America.
New clinical trials using immunotherapy to treat patients with blood cancer has shown ‘extraordinary’ results, according to researchers. The technique involves taking T-cells from the patient, tagging these with ‘receptor’ molecules to target the cancer and then putting them back into the patient's body.
The BSI has released a statement on the reported links between the Zika virus outbreak in Central and South America has and microcephaly in babies as well as Guillain-Barré syndrome, an autoimmune disease that brings about muscle weakness.